[1]
Parsons MA, Harris SC, Longstaff AJ, Grainger RG. Xanthogranulomatous pyelonephritis: a pathological, clinical and aetiological analysis of 87 cases. Diagnostic histopathology. 1983 Jul-Dec:6(3-4):203-19
[PubMed PMID: 6676075]
Level 3 (low-level) evidence
[2]
Chlif M, Chakroun M, Ben Rhouma S, Ben Chehida MA, Sellami A, Gargouri MM, Nouira Y. Xanthogranulomatous pyelonephritis presenting as a pseudotumour. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2016 Jan-Feb:10(1-2):E36-40. doi: 10.5489/cuaj.3225. Epub 2016 Jan 14
[PubMed PMID: 26858786]
[3]
Siddappa S, Ramprasad K, Muddegowda MK. Xanthogranulomatous pyelonephritis: a retrospective review of 16 cases. Korean journal of urology. 2011 Jun:52(6):421-4. doi: 10.4111/kju.2011.52.6.421. Epub 2011 Jun 17
[PubMed PMID: 21750755]
Level 2 (mid-level) evidence
[4]
Rachidi SA, Zeriouel A. [Renal tumor or pseudotumoral xanthogranulomatous pyelonephritis]. The Pan African medical journal. 2018:29():67. doi: 10.11604/pamj.2018.29.67.14611. Epub 2018 Jan 24
[PubMed PMID: 29875948]
[5]
Goyal S, Gupta M, Goyal R. Xanthogranulomatous pyelonephritis: A rare entity. North American journal of medical sciences. 2011 May:3(5):249-50. doi: 10.4297/najms.2011.3249. Epub
[PubMed PMID: 22558604]
[6]
Chandanwale SS. Xanthogranulomatous Pyelonephritis: Unusual Clinical Presentation: A Case Report with Literature Review. Journal of family medicine and primary care. 2013 Oct-Dec:2(4):396-8. doi: 10.4103/2249-4863.123942. Epub
[PubMed PMID: 26664851]
Level 3 (low-level) evidence
[7]
Morales C, Opazo V, Bassa C, López L, Araos F, Madrid P, Morales I. Xanthogranulomatous pyelonephritis: A case report. Urology case reports. 2018 Jul:19():65-66. doi: 10.1016/j.eucr.2018.05.002. Epub 2018 May 11
[PubMed PMID: 29888197]
Level 3 (low-level) evidence
[8]
Kuo CC, Wu CF, Huang CC, Lee YJ, Lin WC, Tsai CW, Wu VC, Chen YM, Wu MS, Chu TS, Wu KD. Xanthogranulomatous pyelonephritis: critical analysis of 30 patients. International urology and nephrology. 2011 Mar:43(1):15-22. doi: 10.1007/s11255-010-9778-8. Epub 2010 Jun 11
[PubMed PMID: 20544282]
[9]
Korkes F, Favoretto RL, Bróglio M, Silva CA, Castro MG, Perez MD. Xanthogranulomatous pyelonephritis: clinical experience with 41 cases. Urology. 2008 Feb:71(2):178-80. doi: 10.1016/j.urology.2007.09.026. Epub
[PubMed PMID: 18308077]
Level 3 (low-level) evidence
[10]
Hodler J, Kubik-Huch RA, von Schulthess GK, Nicola R, Menias CO. Urinary Obstruction, Stone Disease, and Infection. Diseases of the Abdomen and Pelvis 2018-2021: Diagnostic Imaging - IDKD Book. 2018:():
[PubMed PMID: 31314368]
[11]
Akyol Onder EN, Ozkol M, Nese N, Taneli C, Cankorur OO, Ozunan I. Focal Xanthogranulomatous Pyelonephritis in Brachydactyly Mental Retardation Syndrome (2q37 Deletion Syndrome). Journal of pediatric genetics. 2020 Jun:9(2):114-116. doi: 10.1055/s-0039-1697624. Epub 2019 Sep 23
[PubMed PMID: 32341815]
[12]
Jang TL, McKoy T, Hakim J, Polenakovik HM. Xanthogranulomatous pyelonephritis - A diagnostic and therapeutic dilemma. The American journal of the medical sciences. 2023 Mar:365(3):294-301. doi: 10.1016/j.amjms.2022.11.004. Epub 2022 Dec 5
[PubMed PMID: 36473546]
[13]
Abdelnabi M, Rimu A, Suppakitjanusant P, Phy M. Xanthogranulomatous pyelonephritis as a complication of recurrent urinary tract infection. BMJ case reports. 2023 Jan 17:16(1):. doi: 10.1136/bcr-2022-253422. Epub 2023 Jan 17
[PubMed PMID: 36653046]
Level 3 (low-level) evidence
[14]
Li L, Parwani AV. Xanthogranulomatous pyelonephritis. Archives of pathology & laboratory medicine. 2011 May:135(5):671-4
[PubMed PMID: 21526966]
[15]
García-Chairez LR, Robles-Torres JI, Ríos-Palacios RA, Enrriquez-Avila JV, Alcocer-Mey HE, Cervantes-Miranda DE, Gutierrez-González A. Prognostic Factors of Morbimortality in Patients Treated for Xanthogranulomatous Pyelonephritis. Ochsner journal. 2023 Fall:23(3):188-193. doi: 10.31486/toj.23.0002. Epub
[PubMed PMID: 37711470]
[16]
Kundu R, Baliyan A, Dhingra H, Bhalla V, Punia RS. Clinicopathological Spectrum of Xanthogranulomatous Pyelonephritis. Indian journal of nephrology. 2019 Mar-Apr:29(2):111-115. doi: 10.4103/ijn.IJN_50_18. Epub
[PubMed PMID: 30983751]
[17]
Gregg CR, Rogers TE, Munford RS. Xanthogranulomatous pyelonephritis. Current clinical topics in infectious diseases. 1999:19():287-304
[PubMed PMID: 10472491]
[18]
Guerrini V, Gennaro ML. Foam Cells: One Size Doesn't Fit All. Trends in immunology. 2019 Dec:40(12):1163-1179. doi: 10.1016/j.it.2019.10.002. Epub 2019 Nov 12
[PubMed PMID: 31732284]
[19]
Parsons MA, Harris SC, Grainger RG, Ross B, Smith JA, Williams JL. Fistula and sinus formation in xanthogranulomatous pyelonephritis. A clinicopathological review and report of four cases. British journal of urology. 1986 Oct:58(5):488-93
[PubMed PMID: 3779348]
Level 3 (low-level) evidence
[20]
Titus B, Gupta S, Edpao P, Psutka SP, Limaye AP, Bakthavatsalam R, Rakita RM. Xanthogranulomatous Pyelonephritis With Direct Extension Into the Liver. The American journal of medicine. 2020 Sep:133(9):1054-1055. doi: 10.1016/j.amjmed.2019.12.038. Epub 2020 Jan 25
[PubMed PMID: 31991112]
[21]
Zorzos I, Moutzouris V, Korakianitis G, Katsou G. Analysis of 39 cases of xanthogranulomatous pyelonephritis with emphasis on CT findings. Scandinavian journal of urology and nephrology. 2003:37(4):342-7
[PubMed PMID: 12944195]
Level 3 (low-level) evidence
[22]
Chuang CK, Lai MK, Chang PL, Huang MH, Chu SH, Wu CJ, Wu HR. Xanthogranulomatous pyelonephritis: experience in 36 cases. The Journal of urology. 1992 Feb:147(2):333-6
[PubMed PMID: 1732587]
Level 3 (low-level) evidence
[24]
Kim SW, Yoon BI, Ha US, Sohn DW, Cho YH. Xanthogranulomatous pyelonephritis: clinical experience with 21 cases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2013 Dec:19(6):1221-4. doi: 10.1007/s10156-013-0611-z. Epub 2013 May 25
[PubMed PMID: 23708781]
Level 3 (low-level) evidence
[25]
Artiles-Medina A, Laso-García I, Lorca-Álvaro J, Mata-Alcaraz M, Duque-Ruiz G, Hevia-Palacios M, Arias-Funez F, Burgos-Revilla FJ. Xanthogranulomatous pyelonephritis: a focus on microbiological and antibiotic resistance profiles. BMC urology. 2021 Apr 7:21(1):56. doi: 10.1186/s12894-021-00800-z. Epub 2021 Apr 7
[PubMed PMID: 33827527]
[26]
Drăgoescu AN, Pădureanu V, Stănculescu AD, Chiuțu LC, Tomescu P, Geormăneanu C, Pădureanu R, Iovănescu VF, Ungureanu BS, Pănuș A, Drăgoescu OP. Neutrophil to Lymphocyte Ratio (NLR)-A Useful Tool for the Prognosis of Sepsis in the ICU. Biomedicines. 2021 Dec 30:10(1):. doi: 10.3390/biomedicines10010075. Epub 2021 Dec 30
[PubMed PMID: 35052755]
[28]
Dwivedi US, Goyal NK, Saxena V, Acharya RL, Trivedi S, Singh PB, Vyas N, Datta B, Kumar A, Das S. Xanthogranulomatous pyelonephritis: our experience with review of published reports. ANZ journal of surgery. 2006 Nov:76(11):1007-9
[PubMed PMID: 17054551]
[29]
Lee SJ, Yang DM, Kim HC, Kim SW, Won KY, Park SH, Jeong WK. Imaging and Clinical Findings of Xanthogranulomatous Inflammatory Disease of Various Abdominal and Pelvic Organs: A Pictorial Essay. Journal of the Korean Society of Radiology. 2024 Jan:85(1):109-123. doi: 10.3348/jksr.2023.0026. Epub 2023 Dec 9
[PubMed PMID: 38362380]
[30]
Tan WP, Papagiannopoulos D, Elterman L. Bear's Paw Sign: A Classic Presentation of Xanthogranulomatous Pyelonephritis. Urology. 2015 Aug:86(2):e5-6. doi: 10.1016/j.urology.2015.04.033. Epub 2015 Jul 11
[PubMed PMID: 26168999]
[31]
Garrido-Abad P, Rodríguez-Cabello MÁ, Vera-Berón R, Platas-Sancho A. Bear Paw Sign: Xanthogranulomatous Pyelonephritis. Journal of radiology case reports. 2018 Nov:12(11):18-24. doi: 10.3941/jrcr.v12i11.3415. Epub 2018 Nov 30
[PubMed PMID: 30647833]
Level 3 (low-level) evidence
[32]
Tonkaz G, Tonkaz M, Erkal Tonkaz D, Ay M, Pirimoğlu RB. Xanthogranulomatous pyelonephritis: "Bear's paw sign". Medicina clinica. 2024 Feb 20:():. pii: S0025-7753(24)00025-3. doi: 10.1016/j.medcli.2023.11.044. Epub 2024 Feb 20
[PubMed PMID: 38383270]
[33]
Bourm KS, Menias CO, Ali K, Alhalabi K, Elsayes KM. Spectrum of Xanthogranulomatous Processes in the Abdomen and Pelvis: A Pictorial Review of Infectious, Inflammatory, and Proliferative Responses. AJR. American journal of roentgenology. 2017 Mar:208(3):475-484. doi: 10.2214/AJR.16.17075. Epub 2017 Jan 17
[PubMed PMID: 28095017]
[34]
Loffroy R, Guiu B, Watfa J, Michel F, Cercueil JP, Krausé D. Xanthogranulomatous pyelonephritis in adults: clinical and radiological findings in diffuse and focal forms. Clinical radiology. 2007 Sep:62(9):884-90
[PubMed PMID: 17662737]
[35]
Goldman SM, Hartman DS, Fishman EK, Finizio JP, Gatewood OM, Siegelman SS. CT of xanthogranulomatous pyelonephritis: radiologic-pathologic correlation. AJR. American journal of roentgenology. 1984 May:142(5):963-9
[PubMed PMID: 6609582]
[36]
Wu ST. Bear paw sign: classic presentation of xanthogranulomatous pyelonephritis. QJM : monthly journal of the Association of Physicians. 2019 Jun 1:112(6):461-462. doi: 10.1093/qjmed/hcy300. Epub
[PubMed PMID: 30597105]
[37]
Mulopulos GP, Patel SK, Pessis D. MR imaging of xanthogranulomatous pyelonephritis. Journal of computer assisted tomography. 1986 Jan-Feb:10(1):154-6
[PubMed PMID: 3944304]
[38]
Lee GY, Moon SK, You MW, Lim JW. A Case of Xanthogranulomatous Pyelonephritis with Nephropleural Fistula Formation: Role of MRI in Diagnosis and Treatment. Taehan Yongsang Uihakhoe chi. 2021 Mar:82(2):475-480. doi: 10.3348/jksr.2020.0044. Epub 2021 Mar 31
[PubMed PMID: 36238727]
Level 3 (low-level) evidence
[40]
Bolger MP, Hennebry J, Byrne C, Greene L, Stroiescu A, Heneghan J, Ryan AG. Xanthogranulomatous Pyelonephritis: A Narrative Review with Current Perspectives on Diagnostic Imaging and Management, Including Interventional Radiology Techniques. International journal of nephrology and renovascular disease. 2021:14():359-369. doi: 10.2147/IJNRD.S236552. Epub 2021 Sep 7
[PubMed PMID: 34522121]
Level 3 (low-level) evidence
[41]
Nawaz H, Khan S, Hussain I, Ahmed S, Khan M, Niazi N. Xanthogranulomatous pyelonephritis due to calculi: report of 63 cases and review of literature. JPMA. The Journal of the Pakistan Medical Association. 2005 Sep:55(9):387-9
[PubMed PMID: 16302473]
Level 3 (low-level) evidence
[42]
Angulo Madero JM, Arana García J, Eizaguirre Sexmilo I, Barriola Echeverría M, Tovar Larrucea JA. [Xanthogranulomatous pyelonephritis: possibilities of diagnostic imaging]. Anales espanoles de pediatria. 1990 Jul:33(1):50-3
[PubMed PMID: 2252287]
[43]
Kant K, Vyas MC, Pandey SK. Xanthogranulomatous pyelonephritis (report of 2 cases). Journal of postgraduate medicine. 1984 Jan:30(1):42-5
[PubMed PMID: 6716307]
Level 3 (low-level) evidence
[44]
Udare A, Abreu-Gomez J, Krishna S, McInnes M, Siegelman E, Schieda N. Imaging Manifestations of Acute and Chronic Renal Infection That Mimics Malignancy: How to Make the Diagnosis Using Computed Tomography and Magnetic Resonance Imaging. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes. 2019 Nov:70(4):424-433. doi: 10.1016/j.carj.2019.07.002. Epub 2019 Sep 17
[PubMed PMID: 31537315]
[45]
Osca JM, Peiro MJ, Rodrigo M, Martinez-Jabaloyas JM, Jimenez-Cruz JF. Focal xanthogranulomatous pyelonephritis: partial nephrectomy as definitive treatment. European urology. 1997:32(3):375-9
[PubMed PMID: 9358230]
[46]
Ballentine WK 3rd, Vilson F, Dyer RB, Mirzazadeh M. Nephron-sparing management of Xanthogranulomatous pyelonephritis presenting as spontaneous renal hemorrhage: a case report and literature review. BMC urology. 2018 Jun 5:18(1):57. doi: 10.1186/s12894-018-0354-3. Epub 2018 Jun 5
[PubMed PMID: 29866085]
Level 3 (low-level) evidence
[47]
Peréz LM, Thrasher JB, Anderson EE. Successful management of bilateral xanthogranulomatous pyelonephritis by bilateral partial nephrectomy. The Journal of urology. 1993 Jan:149(1):100-2
[PubMed PMID: 8417185]
[48]
Shah KJ, Ganpule AP, Kurien A, Muthu V, Sabnis RB, Desai MR. Laparoscopic versus open nephrectomy for xanthogranulomatous pyelonephritis: An outcome analysis. Indian journal of urology : IJU : journal of the Urological Society of India. 2011 Oct:27(4):470-4. doi: 10.4103/0970-1591.91434. Epub
[PubMed PMID: 22279311]
[49]
Harley F, Wei G, O'Callaghan M, Wong LM, Hennessey D, Kinnear N. Xanthogranulomatous pyelonephritis: a systematic review of treatment and mortality in more than 1000 cases. BJU international. 2023 Apr:131(4):395-407. doi: 10.1111/bju.15878. Epub 2022 Sep 26
[PubMed PMID: 35993745]
Level 1 (high-level) evidence
[50]
Asali M, Tsivian A. Laparoscopic nephrectomy in xanthogranulomatous pyelonephritis. Central European journal of urology. 2019:72(3):319-323. doi: 10.5173/ceju.2019.1891. Epub 2019 Aug 5
[PubMed PMID: 31720037]
[51]
Gravestock P, Moore L, Harding C, Veeratterapillay R. Xanthogranulomatous pyelonephritis: a review and meta-analysis with a focus on management. International urology and nephrology. 2022 Oct:54(10):2445-2456. doi: 10.1007/s11255-022-03253-x. Epub 2022 Jul 9
[PubMed PMID: 35809205]
Level 1 (high-level) evidence
[52]
Pastore V, Niglio F, Basile A, Cocomazzi R, Faticato MG, Aceto G, Bartoli F. Laparascopic-assisted nephroureterectomy for shaped urolithiasis and xanthogranulomatous pyelonephritis: case report and review of literature. African journal of paediatric surgery : AJPS. 2013 Jul-Sep:10(3):285-8. doi: 10.4103/0189-6725.120890. Epub
[PubMed PMID: 24192478]
Level 3 (low-level) evidence
[53]
Guzzo TJ, Bivalacqua TJ, Pierorazio PM, Varkarakis J, Schaeffer EM, Allaf ME. Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy. BJU international. 2009 Nov:104(9):1265-8. doi: 10.1111/j.1464-410X.2009.08547.x. Epub 2009 Apr 15
[PubMed PMID: 19389010]
[54]
Arvind NK, Singh O, Ali Q, Gupta SS, Sahay S. Laparoscopic nephrectomy in xanthogranulomatous pyelonephritis: 7-year single-surgeon outcome. Urology. 2011 Oct:78(4):797-801. doi: 10.1016/j.urology.2011.05.062. Epub 2011 Aug 20
[PubMed PMID: 21862116]
[55]
Kapoor R, Vijjan V, Singh K, Goyal R, Mandhani A, Dubey D, Srivastava A, Kumar A. Is laparoscopic nephrectomy the preferred approach in xanthogranulomatous pyelonephritis? Urology. 2006 Nov:68(5):952-5
[PubMed PMID: 17113885]
[56]
Xie L, Tapiero S, Flores AR, Armas-Phan M, Limfueco L, Karani R, Jiang P, Cobb KD, Sur RL, Chi T, Landman J, Kaler KS, Clayman RV. Long-Term Antibiotic Treatment Prior to Laparoscopic Nephrectomy for Xanthogranulomatous Pyelonephritis Improves Postoperative Outcomes: Results from a Multicenter Study. The Journal of urology. 2021 Mar:205(3):820-825. doi: 10.1097/JU.0000000000001429. Epub 2020 Oct 20
[PubMed PMID: 33080147]
Level 2 (mid-level) evidence
[57]
Shah HN, Jain P, Chibber PJ. Renal tuberculosis simulating xanthogranulomatous pyelonephritis with contagious hepatic involvement. International journal of urology : official journal of the Japanese Urological Association. 2006 Jan:13(1):67-8
[PubMed PMID: 16448435]
[58]
Kwon HJ, Yoo KH, Kim IY, Lee S, Jang HR, Kwon GY. Megalocytic interstitial nephritis following acute pyelonephritis with Escherichia coli bacteremia: a case report. Journal of Korean medical science. 2015 Jan:30(1):110-4. doi: 10.3346/jkms.2015.30.1.110. Epub 2014 Dec 23
[PubMed PMID: 25552891]
Level 3 (low-level) evidence
[59]
Butticè S, Antonino I, Giorgio A, Valeria B, Stefano P, Giuseppe M, Carlo M. Xanthogranulomatous Pyelonephritis Can Simulate a Complex Cyst: Case Description and Review of Literature. Urology case reports. 2014 May:2(3):113-5. doi: 10.1016/j.eucr.2014.03.007. Epub 2014 May 16
[PubMed PMID: 26955560]
Level 3 (low-level) evidence
[60]
Inouye BM, Chiang G, Newbury RO, Holmes N. Adolescent xanthogranulomatous pyelonephritis mimicking renal cell carcinoma on urine cytology: an atypical presentation. Urology. 2013 Apr:81(4):885-7. doi: 10.1016/j.urology.2012.12.019. Epub 2013 Feb 8
[PubMed PMID: 23394878]
[61]
al-Sulaiman MH, al-Khader AA, Mousa DH, al-Swailem RY, Dhar J, Haleem A. Renal parenchymal malacoplakia and megalocytic interstitial nephritis: clinical and histological features. Report of two cases and review of the literature. American journal of nephrology. 1993:13(6):483-8
[PubMed PMID: 8141185]
Level 3 (low-level) evidence
[62]
Herrera-Bedoya M, Avendaño-Capriles CA, Zakzuk-Martinez E, Barrera J. Xanthogranulomatous Pyelonephritis and Its Differential Diagnoses: An In-Depth Case Review. Cureus. 2021 Oct:13(10):e19133. doi: 10.7759/cureus.19133. Epub 2021 Oct 29
[PubMed PMID: 34868771]
Level 3 (low-level) evidence
[63]
AlDarrab RM, AlAkrash HS, AlKhateeb SS, AlBqami NM. A case report of a xanthogranulomatous pyelonephritis case mimicking the recurrence of renal cell carcinoma after partial nephrectomy. Urology annals. 2015 Oct-Dec:7(4):524-6. doi: 10.4103/0974-7796.164857. Epub
[PubMed PMID: 26692680]
Level 3 (low-level) evidence
[64]
Banerjee I, Tomar V, Yadav SS, Vyas N, Talreja S. Xanthogranulomatous pyelonephritis presenting as a type IV renal cyst. Reviews in urology. 2017:19(1):60-63
[PubMed PMID: 28522934]
[65]
Robles-Torres JI, García-Chairez LR, Castellani D, Enrriquez-Ávila JV, Monzón-Falconi JF, Esqueda-Mendoza A, Flores-Tapia JP, Wroclawski ML, Duarte-Santos HO, Ragoori D, Gadzhiev N, Mahajan A, Kumar S, Farooq M, Ganpule A, Tanidir Y, Maheshwari PN, Gite VA, Sinha MM, Somani BK, Gutiérrez-González A, Gauhar V. Perioperative outcomes and risk factors for major complications associated with nephrectomy for Xanthogranulomatous pyelonephritis: a multicenter study. World journal of urology. 2023 Nov:41(11):2905-2914. doi: 10.1007/s00345-023-04415-x. Epub 2023 May 12
[PubMed PMID: 37171477]
Level 2 (mid-level) evidence
[66]
Habuka M, Nishikiori M, Oikawa C, Takahashi M, Sakamaki Y, Ogawa A, Miyajima N, Tanabe Y, Honma K, Wakaki K, Yamamoto S, Narita I. Systemic Amyloid A Amyloidosis Secondary to Xanthogranulomatous Pyelonephritis. Internal medicine (Tokyo, Japan). 2024 Feb 15:63(4):593-599. doi: 10.2169/internalmedicine.1806-23. Epub 2023 Jul 5
[PubMed PMID: 37407464]
[67]
Numan L, Zamir H, Husainat NM, Tahboub M. Xanthogranulomatous Pyelonephritis Causing Renocolic Fistula Presenting as Symptomatic Anemia. Cureus. 2019 Jun 19:11(6):e4947. doi: 10.7759/cureus.4947. Epub 2019 Jun 19
[PubMed PMID: 31453021]
[68]
Leslie SW, Sajjad H, Bashir K. 24-Hour Urine Testing for Nephrolithiasis: Interpretation and Treatment Guidelines. StatPearls. 2024 Jan:():
[PubMed PMID: 29494055]
[69]
Lauzurica R, Felip A, Serra A, Saladie JM, Montserrat E, Encabo B, Caralps A. Xanthogranulomatous pyelonephritis and systemic amyloidosis: report of 2 new cases and the natural history of this association. The Journal of urology. 1991 Dec:146(6):1603-6
[PubMed PMID: 1942352]
Level 3 (low-level) evidence
[70]
Akhtar M, Qunibi W. Bilateral xanthogranulomatous pyelonephritis involving native kidneys in a renal transplant recipient: association with renal cell carcinoma and amyloidosis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1992 Sep:20(3):289-93
[PubMed PMID: 1519612]
[71]
Veerabathini BC, Manthani K, Gandhi S, Duddala N. A Very Rare Case of Primary Renal Squamous Cell Carcinoma Presenting With Xanthogranulomatous Pyelonephritis on Radiological Imaging. Cureus. 2020 Dec 3:12(12):e11871. doi: 10.7759/cureus.11871. Epub 2020 Dec 3
[PubMed PMID: 33282610]
Level 3 (low-level) evidence
[72]
Chang TH, Tseng JS. Rare squamous cell carcinoma of the kidney with concurrent xanthogranulomatous pyelonephritis: A case report and review of the literature. Open medicine (Warsaw, Poland). 2021:16(1):128-133. doi: 10.1515/med-2020-0233. Epub 2021 Jan 12
[PubMed PMID: 33521318]
Level 3 (low-level) evidence
[73]
Yousof A, Aldhilan A, Alamer A, Fahad A. Renal Squamous Cell Carcinoma Presented With Bone Metastasis and Coexistence With Xanthogranulomatous Pyelonephritis: A Case Report. Urology case reports. 2014 Mar:2(2):35-7. doi: 10.1016/j.eucr.2013.12.009. Epub 2014 Mar 12
[PubMed PMID: 26955541]
Level 3 (low-level) evidence
[74]
Ho CI, Wen YK, Chen ML. Xanthogranulomatous pyelonephritis successfully treated with antibiotics only. Journal of the Chinese Medical Association : JCMA. 2008 Dec:71(12):643-5. doi: 10.1016/S1726-4901(09)70008-5. Epub
[PubMed PMID: 19114330]
[75]
Brown PS Jr, Dodson M, Weintrub PS. Xanthogranulomatous pyelonephritis: report of nonsurgical management of a case and review of the literature. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1996 Feb:22(2):308-14
[PubMed PMID: 8838188]
Level 3 (low-level) evidence
[76]
Reul O, Waltregny D, Boverie J, de Leval J, Andrianne R. [Pseudotumoral xanthogranulomatous pyelonephritis: diagnosis with percutaneous biopsy and success of conservative treatment]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2001 Dec:11(6):1274-6
[PubMed PMID: 11859664]
[77]
Gasmi M, Jemai R, Fitouri F, Ben Slama A, Sahli S, Hamzaoui M. Xanthogranulomatous pyelonephritis in childhood: diagnosis difficulties and success of conservative treatment. La Tunisie medicale. 2010 Jun:88(6):427-9
[PubMed PMID: 20517855]
[78]
Fitouri Z, Nouira Y, Nouira K, Sallami S, Hmidi M, El Fekih N, Horchani A. Focal xanthogranulomatous pyelonephritis: success of conservative treatment. A case report. La Tunisie medicale. 2008 Oct:86(10):912-5
[PubMed PMID: 19472811]
Level 3 (low-level) evidence